UnitedHealth Group (NYSE:UNH) Updates FY19 Earnings Guidance

UnitedHealth Group (NYSE:UNH) updated its FY19 earnings guidance on Monday. The company provided earnings per share guidance of approach $15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.83. The company issued revenue guidance of ~$242 billion, compared to the consensus revenue estimate of $242.73 billion.UnitedHealth Group also updated its FY20 guidance to $16.25-16.55 EPS.

A number of research analysts have weighed in on the stock. Morgan Stanley reiterated a buy rating and issued a $312.00 target price (up from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. Barclays boosted their target price on shares of UnitedHealth Group from $260.00 to $305.00 and gave the company an overweight rating in a research note on Monday. Jefferies Financial Group cut shares of UnitedHealth Group from a buy rating to a hold rating and dropped their target price for the company from $300.00 to $235.00 in a research note on Thursday, October 10th. Mizuho reiterated a buy rating and issued a $300.00 target price (up from $270.00) on shares of UnitedHealth Group in a research note on Tuesday, November 26th. Finally, UBS Group dropped their target price on shares of UnitedHealth Group from $281.00 to $257.00 and set a neutral rating on the stock in a research note on Thursday, October 17th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $289.39.

Shares of NYSE UNH traded down $0.21 during midday trading on Monday, hitting $279.66. The company’s stock had a trading volume of 2,517,060 shares, compared to its average volume of 4,483,900. The stock has a fifty day moving average price of $258.05 and a 200 day moving average price of $245.34. UnitedHealth Group has a one year low of $208.07 and a one year high of $287.94. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $265.15 billion, a price-to-earnings ratio of 21.71, a P/E/G ratio of 1.48 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The company had revenue of $60.35 billion for the quarter, compared to analyst estimates of $59.84 billion. During the same quarter in the previous year, the firm posted $3.41 earnings per share. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group will post 14.96 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date is Friday, December 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.

In related news, EVP D Ellen Wilson sold 7,400 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $233.40, for a total transaction of $583,500.00. Following the sale, the director now directly owns 187,979 shares in the company, valued at approximately $43,874,298.60. The disclosure for this sale can be found here. Insiders have sold a total of 38,577 shares of company stock worth $9,398,080 in the last ninety days. 0.82% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What are the qualifications of a portfolio manager?

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply